Association between neuropsychological assessment and amyloid status in a clinical setting.
Laura E KorthauerZachary T GemelliDeirdre O'SheaBrian R OttJennifer D DavisPublished in: Neuropsychology (2024)
Comprehensive neuropsychological assessment showed modest concordance with AD biomarker status in patients seen in an outpatient medical center for routine clinical care. Low specificity for the clinical diagnosis of AD could be explained by the multiplicity of etiologies that cause memory impairment (i.e., TAR DNA-binding protein 43, suspected non-AD pathology). (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Keyphrases
- binding protein
- healthcare
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- emergency department
- mild cognitive impairment
- prognostic factors
- peritoneal dialysis
- pulmonary embolism
- single molecule
- pain management
- chronic pain
- clinical practice
- circulating tumor
- patient reported outcomes
- affordable care act